Clinical Report: Understanding Follicular Development in the Menstrual Cycle's Follicular Phase

Overview

This report examines the role of luteinizing hormone receptor (LHR) function in follicular development during the menstrual cycle. Findings from the Rainbow RCT indicate that exogenous LH-like activity may adversely affect reproductive outcomes, highlighting the need for further investigation into LHR dynamics in ovarian stimulation.

Background

Follicular development is crucial for successful ovulation and fertility, with LHR playing a significant role in this process. Despite the long-standing use of LH-like activity in ovarian stimulation protocols, recent trials have shown inconsistent benefits, indicating a gap in understanding LHR's physiological role. Clarifying LHR function could enhance ovarian stimulation strategies and improve reproductive outcomes.

Data Highlights

No numerical data available.

Key Findings

• In the Rainbow RCT, increasing doses of recombinant hCG (rhCG) led to a dose-dependent reduction in good-quality blastocysts and ongoing pregnancy rates.
• Androstenedione, 17-OH-progesterone, testosterone, and oestradiol levels increased with higher rhCG doses, while progesterone, inhibin-A, and inhibin-B levels decreased.
• Granulosa cells (GCs) exhibited altered function due to rhCG exposure, despite theca cells (TCs) maintaining responsiveness.
• LHR expression and signaling differ between GCs and TCs, suggesting distinct regulatory mechanisms during folliculogenesis.
• Constant exposure to rhCG may disrupt normal receptor dynamics, affecting GC function.
• Current guidelines recommend individualized approaches to gonadotropin use in ovarian stimulation, emphasizing the limited benefit of routine LH supplementation.

Clinical Implications

Healthcare professionals should consider the implications of LHR dynamics when designing ovarian stimulation protocols. The findings suggest that reliance on exogenous LH-like activity may not yield the expected benefits and could potentially hinder reproductive outcomes.

Conclusion

The insights from the Rainbow RCT underscore the complexity of LHR function in follicular development, necessitating further research to optimize ovarian stimulation strategies and improve fertility treatments.

Related Resources & Content

1. Fernández Sánchez et al., Frontiers in Endocrinology, 2022 -- The ovulation trigger method affects gonadotropin concentrations and gonadotropin receptor expression during final oocyte maturation in women
2. Frontiers in Endocrinology, 2022 -- Functional data analysis of FSH and inhibin B levels in four ovulatory cycles shows a changing oscillatory interaction during the follicular phase
3. The Journal of Clinical Endocrinology & Metabolism, 2022 -- Differential Luteinization Characteristics of Cultured Human Granulosa Cells Derived from Small Antral and Preovulatory Follicles
4. New insights into the ovulatory process in the human ovary - PMC, 2023
5. ESHRE guideline: ovarian stimulation for IVF/ICSI: an update in 2025 - PMC
6. Frontiers in Endocrinology — Correction: Regulatory actions of LH and follicle-stimulating hormone on breast cancer cells and mammary tumors in rats
7. Are the various treatments used to stimulate the ovaries in women undergoing in vitro fertilisation (IVF) effective and safe? | Cochrane
8. New insights into the ovulatory process in the human ovary - PMC
9. ESHRE guideline: ovarian stimulation for IVF/ICSI: an update in 2025 - PMC